BICLUSTER_ID : UPREG-162
PATHOGENS /3/ : listeria monocytogenes,escherichia coli,brucella ovis
TARGETS /19/ : PDE4B, TNFRSF1B, IL3RA, GFPT2, GCH1, UGCG, PIM1, CXCL10, NFKB1, STAT1, CCL8, TOP1, IFNB1, IL6, IL1B, PTGS2, MAPKAPK2, PLAUR, TNF
Gene SetLeading Edge Genes
NETPATH TNF ALPHA PATHWAY UPCSF3, HBEGF, PSMA2, GFPT2, NFKBIA, THPO, GCH1, INHBA, PSMA3, UGCG, CXCL2, SOD2, CXCL10, EMP3, NFKB1, TNIP1, JUNB, GBP2, IFITM3, IL1B, TNFAIP3, BID, NFKBIB, ISGF3G, PSMA5, TMSB10, TNFRSF1B, IL3RA, PDCD5, CSF2, IFIT2, PTX3, IER3, PDGFB, ADAM17, TRIM21, ETS2, IFNB1, IL6, PTGS2, IFI27, PLAUR
NETPATH IL 2 PATHWAY UPAHR, PDE4B, GBP1, ISGF3G, TNFRSF1B, NMI, SOCS3, PIM1, CSF2, CCL4, IER3, NFKB1, IFIT1, STAT1, TOP1, TRIM21, SRC, ETS2, IFITM3, LCP2, IL6, IL1B, MAPKAPK2, UPP1, TNF, PLAUR
NETPATH IL 1 PATHWAY UPNFKB1, CCL8, HBEGF, IL1A, NFKBIA, IL6, PTGS2, IL1B, PIM2, MT2A, CXCL2, CSF2, SOD2, CCL4
NCI IL23PATHWAYSOCS3, NFKB1, NFKBIA, STAT1, IL1B, TNF
NETPATH IL 3 PATHWAY UPSOCS3, IL3RA, CCL7, IL1B, PIM1, MYC, CCL4, TNF
NETPATH IL 4 PATHWAY DOWNPDGFB, STAT1, NFKBIA, GADD45B, PTGS2, CXCL2, TNF
NETPATH IL 6 PATHWAY UPSTAT1, GADD45B, JUNB, NMI, SOCS3, PIM2, PIM1, TNF
NETPATH IL 5 PATHWAY UPNFKB1, PDE4B, IL1B, UPP1, IL1A, IER3
NETPATH IL 1 PATHWAYNFKB1, NFKBIA, IL1RN, IL1B, PELI1, IL1A
NETPATH EGFR1 PATHWAY UPEHD1, PTGS2, HBEGF, PHLDA2, PLAUR, IER3
BIOCARTA IL10 PATHWAY
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
BIOCARTA STEM PATHWAY
BIOCARTA NFKB PATHWAY
MAHAJAN RESPONSE TO IL1A UP
WEINMANN ADAPTATION TO HYPOXIA DN
KEGG GRAFT VERSUS HOST DISEASE
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
ZHU CMV 24 HR UP
MUELLER COMMON TARGETS OF AML FUSIONS DN
LINDSTEDT DENDRITIC CELL MATURATION B
BIOCARTA IL1R PATHWAY
NCI HOST INTERACTIONS OF HIV FACTORS
BIOCARTA RELA PATHWAY
LINDSTEDT DENDRITIC CELL MATURATION A
RADAEVA RESPONSE TO IFNA1 UP
BOWIE RESPONSE TO EXTRACELLULAR MATRIX
NETPATH IL 7 PATHWAY UP
REACTOME SCF SKP2 MEDIATED DEGRADATION OF P27 P21
NCI SCF SKP2 MEDIATED DEGRADATION OF P27 P21
BROWNE INTERFERON RESPONSIVE GENES
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
NCI DISSOLUTION OF FIBRIN CLOT
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
LENAOUR DENDRITIC CELL MATURATION DN
HINATA NFKB TARGETS KERATINOCYTE UP
CORUM PA28GAMMA-20S PROTEASOMEPSMA1, PSMA6, PSMA3, PSMA2, PSMA5
DORN ADENOVIRUS INFECTION 48HR DN
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
XU HGF TARGETS INDUCED BY AKT1 48HR UP
OSADA ASCL1 TARGETS DN
VART KSHV INFECTION ANGIOGENIC MARKERS UP
AMIT SERUM RESPONSE 60 MCF10A
BIOCARTA PROTEASOME PATHWAY
DUTTA APOPTOSIS VIA NFKB
COULOUARN TEMPORAL TGFB1 SIGNATURE UP
DIRMEIER LMP1 RESPONSE EARLY
NCI VPU MEDIATED DEGRADATION OF CD4
SEITZ NEOPLASTIC TRANSFORMATION BY 8P DELETION UP
BENNETT SYSTEMIC LUPUS ERYTHEMATOSUS
ZHOU INFLAMMATORY RESPONSE LIVE UP
ONDER CDH1 TARGETS 3 DN
AMIT EGF RESPONSE 120 HELA
VART KSHV INFECTION ANGIOGENIC MARKERS DN
MCLACHLAN DENTAL CARIES UP
DAZARD RESPONSE TO UV NHEK UP
ISHIKAWA STING SIGNALING
FOSTER INFLAMMATORY RESPONSE LPS DN
REACTOME P53 INDEPENDENT DNA DAMAGE RESPONSE
GAURNIER PSMD4 TARGETS
HELLER SILENCED BY METHYLATION UP
GRANDVAUX IFN RESPONSE NOT VIA IRF3
BOWIE RESPONSE TO TAMOXIFEN
SMID BREAST CANCER LUMINAL B DN
ZHOU INFLAMMATORY RESPONSE LPS UP
BOQUEST STEM CELL CULTURED VS FRESH DN
AMIT SERUM RESPONSE 120 MCF10A
FINAK BREAST CANCER SDPP SIGNATURE
DORN ADENOVIRUS INFECTION 24HR DN
REACTOME REGULATION OF ORNITHINE DECARBOXYLASE
SESTO RESPONSE TO UV C3
VERHAAK AML WITH NPM1 MUTATED UP
GEISS RESPONSE TO DSRNA UP
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1
NCI IL12 2PATHWAY
ZHOU INFLAMMATORY RESPONSE FIMA UP
SANCHEZ MDM2 TARGETS
TIAN TNF SIGNALING VIA NFKB
ZHU CMV ALL UP
KEGG SYSTEMIC LUPUS ERYTHEMATOSUS
NCI SCF BETA TRCP MEDIATED DEGRADATION OF EMI1
KEGG PROTEASOME
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY
NCI REGULATION OF ACTIVATED PAK 2P34 BY PROTEASOME MEDIATED DEGRADATION1
NCI VIF MEDIATED DEGRADATION OF APOBEC3G
LEE LIVER CANCER HEPATOBLAST
NCI DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX
NAGASHIMA EGF SIGNALING UP
HOFMANN MYELODYSPLASTIC SYNDROM LOW RISK DN
KEGG TYPE I DIABETES MELLITUS
HINATA NFKB TARGETS FIBROBLAST UP
AMIT EGF RESPONSE 60 MCF10A
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
GRADE METASTASIS DN
ZHANG INTERFERON RESPONSE
SESTO RESPONSE TO UV C1
AUJLA IL22 AND IL17A SIGNALING
DORN ADENOVIRUS INFECTION 32HR DN
CROONQUIST STROMAL STIMULATION UP
SA MMP CYTOKINE CONNECTION
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D UP
SIMBULAN UV RESPONSE NORMAL UP
CORUM PA28-20S PROTEASOMEPSMA6, PSMA3, PSMA2, PSMA5
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN UP
DORN ADENOVIRUS INFECTION 12HR UP
MAHADEVAN RESPONSE TO MP470 DN
UROSEVIC RESPONSE TO IMIQUIMOD
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D UP
BUDHU LIVER CANCER METASTASIS DN
NETPATH KIT RECEPTOR PATHWAY UP
DIRMEIER LMP1 RESPONSE LATE UP
SEIKE LUNG CANCER POOR SURVIVAL
BASSO CD40 SIGNALING UP
SOUCEK MYC TARGETS
MARZEC IL2 SIGNALING UP
BOYLAN MULTIPLE MYELOMA C D DN
FERRARI RESPONSE TO FENRETINIDE UP
BIOCARTA TID PATHWAY
KEGG RIG I LIKE RECEPTOR SIGNALING PATHWAY
BILD HRAS ONCOGENIC SIGNATURE
DAUER STAT3 TARGETS UP
LIANG SILENCED BY METHYLATION 2
REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G
KEGG LEISHMANIA INFECTION
SCHEIDEREIT IKK TARGETS
ZUCCHI METASTASIS UP
BERENJENO TRANSFORMED BY RHOA FOREVER DN
PELLICCIOTTA HDAC IN ANTIGEN PRESENTATION DN
MARKS HDAC TARGETS DN
DAZARD UV RESPONSE CLUSTER G2
RORIE TARGETS OF EWSR1 FLI1 FUSION UP
MCLACHLAN DENTAL CARIES DN
KEGG ALLOGRAFT REJECTION
AMIT SERUM RESPONSE 40 MCF10A
SEKI INFLAMMATORY RESPONSE LPS UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
SANA TNF SIGNALING UP
BIOCARTA INFLAM PATHWAY
MOSERLE IFNA RESPONSE
NCI UBIQUITIN DEPENDENT DEGRADATION OF CYCLIN D1
FOSTER INFLAMMATORY RESPONSE LPS UP
XU HGF TARGETS INDUCED BY AKT1 6HR
ONDER CDH1 TARGETS 2 DN
AMIT EGF RESPONSE 240 HELA
CORUM 20S PROTEASOMEPSMA1, PSMA6, PSMA3, PSMA2, PSMA5
REACTOME STABILIZATION OF P53
NCI REGULATION OF ORNITHINE DECARBOXYLASE ODC
CORUM 26S PROTEASOME
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
PEPPER CHRONIC LYMPHOCYTIC LEUKEMIA UP
KIM WT1 TARGETS UP
VECCHI GASTRIC CANCER ADVANCED VS EARLY UP
ONDER CDH1 TARGETS 1 DN
KEGG CYTOSOLIC DNA SENSING PATHWAY
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
XU HGF SIGNALING NOT VIA AKT1 6HR
DASU IL6 SIGNALING UP
AMIT EGF RESPONSE 120 MCF10A
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
NCI REGULATION OF ACTIVATED PAK 2P34 BY PROTEASOME MEDIATED DEGRADATION
ZUCCHI METASTASIS DN
NCI UBIQUITIN MEDIATED DEGRADATION OF PHOSPHORYLATED CDC25A
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
listeria monocytogenesbrucella ovisescherichia coliGeneSet Name
0.00123 0.15651 0.00001NETPATH_TNF_ALPHA_PATHWAY_UP
0.00068 0.18663 0.00000NETPATH_IL_2_PATHWAY_UP
0.00000 0.01452 0.00000NETPATH_IL_1_PATHWAY_UP
0.00100 0.05836 0.00000NCI_IL23PATHWAY
0.00553 0.00156 0.00000NETPATH_IL_3_PATHWAY_UP
0.00001 0.00062 0.00000NETPATH_IL_4_PATHWAY_DOWN
0.00233 0.01065 0.00000NETPATH_IL_6_PATHWAY_UP
0.00007 0.03173 0.00001NETPATH_IL_5_PATHWAY_UP
0.00142 0.08064 0.00003NETPATH_IL_1_PATHWAY
0.03270 0.19976 0.00008NETPATH_EGFR1_PATHWAY_UP
0.00014 0.16352 0.00002BIOCARTA_IL10_PATHWAY
0.00023 0.07308 0.00000GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.05829 0.16927 0.00008BIOCARTA_STEM_PATHWAY
0.08391 0.12428 0.00000BIOCARTA_NFKB_PATHWAY
0.00046 0.08148 0.00000MAHAJAN_RESPONSE_TO_IL1A_UP
0.01186 0.07459 0.00000WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.00003 0.01234 0.00002KEGG_GRAFT_VERSUS_HOST_DISEASE
0.00001 0.03248 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.00001 0.08859 0.00000ZHU_CMV_24_HR_UP
0.03122 0.05503 0.03638MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.00437 0.02851 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.00776 0.03199 0.00000BIOCARTA_IL1R_PATHWAY
0.00045 0.03263 0.08644NCI_HOST_INTERACTIONS_OF_HIV_FACTORS
0.07380 0.15619 0.00033BIOCARTA_RELA_PATHWAY
0.00000 0.00044 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.00000 0.11979 0.00000RADAEVA_RESPONSE_TO_IFNA1_UP
0.00007 0.19318 0.00001BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.09197 0.01316 0.00000NETPATH_IL_7_PATHWAY_UP
0.00028 0.03357 0.15073REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21
0.00110 0.08116 0.09524NCI_SCF_SKP2__MEDIATED_DEGRADATION_OF_P27_P21
0.00000 0.12548 0.00000BROWNE_INTERFERON_RESPONSIVE_GENES
0.00000 0.06140 0.00000THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.17554 0.16625 0.12964NCI_DISSOLUTION_OF_FIBRIN_CLOT
0.00008 0.18029 0.00220TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.00005 0.11409 0.02437LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.00001 0.03817 0.00000HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.00011 0.01273 0.01008CORUM_PA28GAMMA-20S_PROTEASOME
0.00579 0.09920 0.00089DORN_ADENOVIRUS_INFECTION_48HR_DN
0.00736 0.05857 0.00000KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.04325 0.09865 0.00136XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.04416 0.17587 0.00002OSADA_ASCL1_TARGETS_DN
0.01472 0.10314 0.00000VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.02234 0.11740 0.00109AMIT_SERUM_RESPONSE_60_MCF10A
0.00016 0.01489 0.02266BIOCARTA_PROTEASOME_PATHWAY
0.01422 0.01264 0.00000DUTTA_APOPTOSIS_VIA_NFKB
0.03942 0.08879 0.01809COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.00199 0.01330 0.00000DIRMEIER_LMP1_RESPONSE_EARLY
0.00119 0.08155 0.13037NCI_VPU_MEDIATED_DEGRADATION_OF_CD4
0.00001 0.03492 0.00000SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.00000 0.05898 0.00000BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.00000 0.00746 0.00000ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.00011 0.00115 0.00000ONDER_CDH1_TARGETS_3_DN
0.02592 0.12378 0.00046AMIT_EGF_RESPONSE_120_HELA
0.06178 0.11356 0.08667VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
0.00000 0.03202 0.00000MCLACHLAN_DENTAL_CARIES_UP
0.01225 0.12521 0.00002DAZARD_RESPONSE_TO_UV_NHEK_UP
0.02022 0.12495 0.00301ISHIKAWA_STING_SIGNALING
0.00001 0.01159 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00031 0.03125 0.13847REACTOME_P53_INDEPENDENT_DNA_DAMAGE_RESPONSE
0.00001 0.00581 0.00000GAURNIER_PSMD4_TARGETS
0.07324 0.11472 0.00002HELLER_SILENCED_BY_METHYLATION_UP
0.00061 0.10265 0.00002GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
0.00001 0.09220 0.00000BOWIE_RESPONSE_TO_TAMOXIFEN
0.12803 0.19116 0.00006SMID_BREAST_CANCER_LUMINAL_B_DN
0.00000 0.04278 0.00000ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.05101 0.00601 0.17948BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN
0.00040 0.01293 0.00011AMIT_SERUM_RESPONSE_120_MCF10A
0.16995 0.17075 0.08992FINAK_BREAST_CANCER_SDPP_SIGNATURE
0.00441 0.12363 0.00667DORN_ADENOVIRUS_INFECTION_24HR_DN
0.00069 0.13579 0.11712REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE
0.00002 0.12374 0.00001SESTO_RESPONSE_TO_UV_C3
0.00000 0.08159 0.00000VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.00027 0.08028 0.00000GEISS_RESPONSE_TO_DSRNA_UP
0.07166 0.19115 0.00653SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.04187 0.14294 0.00000NCI_IL12_2PATHWAY
0.00125 0.01646 0.00000ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.00227 0.18896 0.01436SANCHEZ_MDM2_TARGETS
0.00054 0.02617 0.00000TIAN_TNF_SIGNALING_VIA_NFKB
0.00000 0.06104 0.00000ZHU_CMV_ALL_UP
0.00001 0.05898 0.08323KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.00045 0.08031 0.08611NCI_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
0.00038 0.03342 0.00631KEGG_PROTEASOME
0.02242 0.13418 0.00000KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.00062 0.04956 0.13298NCI_REGULATION_OF_ACTIVATED_PAK_2P34_BY_PROTEASOME_MEDIATED_DEGRADATION1
0.00069 0.03866 0.09578NCI_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.02848 0.15857 0.00010LEE_LIVER_CANCER_HEPATOBLAST
0.00037 0.18023 0.13163NCI_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX
0.00001 0.19801 0.00003NAGASHIMA_EGF_SIGNALING_UP
0.02089 0.18479 0.11170HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN
0.00007 0.14828 0.00002KEGG_TYPE_I_DIABETES_MELLITUS
0.00031 0.16302 0.00000HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.01523 0.03197 0.00000AMIT_EGF_RESPONSE_60_MCF10A
0.02915 0.03342 0.00000KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.00001 0.01964 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.01744 0.17225 0.05569GRADE_METASTASIS_DN
0.00000 0.14676 0.00000ZHANG_INTERFERON_RESPONSE
0.00001 0.12145 0.00038SESTO_RESPONSE_TO_UV_C1
0.00510 0.13604 0.00129AUJLA_IL22_AND_IL17A_SIGNALING
0.01095 0.03181 0.00003DORN_ADENOVIRUS_INFECTION_32HR_DN
0.05925 0.01979 0.00003CROONQUIST_STROMAL_STIMULATION_UP
0.04438 0.18285 0.00133SA_MMP_CYTOKINE_CONNECTION
0.00001 0.12412 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.04183 0.05634 0.01024SIMBULAN_UV_RESPONSE_NORMAL_UP
0.00254 0.01964 0.00140CORUM_PA28-20S_PROTEASOME
0.07255 0.12619 0.00057ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
0.02117 0.03636 0.04767DORN_ADENOVIRUS_INFECTION_12HR_UP
0.01146 0.06080 0.00317MAHADEVAN_RESPONSE_TO_MP470_DN
0.00008 0.06159 0.00000UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.00000 0.04753 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.03733 0.08131 0.00126BUDHU_LIVER_CANCER_METASTASIS_DN
0.05671 0.17580 0.00023NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.12444 0.03254 0.00000DIRMEIER_LMP1_RESPONSE_LATE_UP
0.00438 0.05722 0.00018SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.00020 0.08843 0.00000BASSO_CD40_SIGNALING_UP
0.09270 0.00716 0.00037SOUCEK_MYC_TARGETS
0.00507 0.05261 0.00002MARZEC_IL2_SIGNALING_UP
0.12871 0.18270 0.05549BOYLAN_MULTIPLE_MYELOMA_C_D_DN
0.06128 0.08101 0.00016FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.07253 0.16728 0.00058BIOCARTA_TID_PATHWAY
0.05669 0.12476 0.00000KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.00000 0.06372 0.00000BILD_HRAS_ONCOGENIC_SIGNATURE
0.00016 0.10980 0.00003DAUER_STAT3_TARGETS_UP
0.00001 0.03860 0.00000LIANG_SILENCED_BY_METHYLATION_2
0.00069 0.03399 0.04833REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.00055 0.13650 0.00028KEGG_LEISHMANIA_INFECTION
0.12320 0.14263 0.00617SCHEIDEREIT_IKK_TARGETS
0.01901 0.12139 0.11573ZUCCHI_METASTASIS_UP
0.03353 0.17996 0.00016BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.00306 0.04589 0.09136PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN
0.01133 0.14666 0.00070MARKS_HDAC_TARGETS_DN
0.04745 0.14937 0.00004DAZARD_UV_RESPONSE_CLUSTER_G2
0.00899 0.05789 0.07388RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.00000 0.04417 0.00002MCLACHLAN_DENTAL_CARIES_DN
0.00001 0.13146 0.00000KEGG_ALLOGRAFT_REJECTION
0.00799 0.08142 0.00142AMIT_SERUM_RESPONSE_40_MCF10A
0.00000 0.00076 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00097 0.05672 0.00000GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00000 0.00055 0.00000ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.00000 0.01931 0.00000SANA_TNF_SIGNALING_UP
0.00012 0.00765 0.00000BIOCARTA_INFLAM_PATHWAY
0.00000 0.05076 0.00000MOSERLE_IFNA_RESPONSE
0.00081 0.02768 0.03879NCI_UBIQUITIN_DEPENDENT_DEGRADATION_OF_CYCLIN_D1
0.00000 0.08922 0.00011FOSTER_INFLAMMATORY_RESPONSE_LPS_UP
0.00954 0.12444 0.00014XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.00554 0.13624 0.00002ONDER_CDH1_TARGETS_2_DN
0.00272 0.06176 0.00023AMIT_EGF_RESPONSE_240_HELA
0.00025 0.01291 0.01632CORUM_20S_PROTEASOME
0.00163 0.07503 0.17726REACTOME_STABILIZATION_OF_P53
0.00061 0.03307 0.11477NCI_REGULATION_OF_ORNITHINE_DECARBOXYLASE__ODC_
0.00002 0.00480 0.06610CORUM_26S_PROTEASOME
0.00000 0.00038 0.00000HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.00698 0.08045 0.00611PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.01564 0.09311 0.00002KIM_WT1_TARGETS_UP
0.00309 0.15058 0.00166VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
0.00003 0.11964 0.00021ONDER_CDH1_TARGETS_1_DN
0.00588 0.03178 0.00000KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.00007 0.01384 0.00044UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.00146 0.04999 0.00132XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.00595 0.14484 0.00015DASU_IL6_SIGNALING_UP
0.00423 0.12289 0.00004AMIT_EGF_RESPONSE_120_MCF10A
0.00001 0.00040 0.00000GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00001 0.01906 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.00056 0.03113 0.06877NCI_REGULATION_OF_ACTIVATED_PAK_2P34_BY_PROTEASOME_MEDIATED_DEGRADATION
0.00518 0.10002 0.00000ZUCCHI_METASTASIS_DN
0.00046 0.04348 0.11597NCI_UBIQUITIN_MEDIATED_DEGRADATION_OF_PHOSPHORYLATED_CDC25A